Adverse Events Associated With Radium-223 in Metastatic Prostate Cancer: Disproportionality Analysis of FDA Data Reflecting Worldwide Utilization.

Huynh-Le, Minh-Phuong; Shults, Randall C; Connor, Michael J; Hattangadi-Gluth, Jona A

Huynh-Le, Minh-Phuong; Shults, Randall C; Connor, Michael J; Hattangadi-Gluth, Jona A.

Affiliation

Huynh-Le MP; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA.
Shults RC; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA.
Connor MJ; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA.
Hattangadi-Gluth JA; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA. Electronic address: jhattangadi@ucsd.edu.

Clin Genitourin Cancer ; 18(3): 192-200.e2, 2020 06.

Article de En | MEDLINE | ID: mdl-31902714

Sujet(s)
Mots clés

Disproportionality analysis; FAERS; Pharmacovigilance; Radium-223; Unsealed source radiotherapy

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Radium / Appréciation des risques / Effets secondaires indésirables des médicaments Type d'étude: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Aged80 / Humans / Male / Middle aged Pays/Région comme sujet: America do norte Langue: En Journal: Clin Genitourin Cancer Sujet du journal: NEOPLASIAS / UROLOGIA Année: 2020 Type de document: Article Pays d'affiliation: Canada Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google